US FDA’s Fast Track Designation Policy Faces Unusual Legal Challenge

Fast track
US FDA sued for refusing to designate a drug for fast track process • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership